CHAIN at Microbiome Conferences in June
CHAIN Chief Executive Dr Edward Green will be speaking at the 2nd Annual Microbiome...read more
CHAIN Biotechnology Ltd was founded by Dr Edward Green in 2014 to develop new Clostridium-based microbial technology for high value healthcare products. CHAIN produces novel live biotherapeutic products (LBPs) for chronic gut-related diseases, such as Inflammatory Bowel Disease (IBD).
At the heart of CHAIN’s unique therapeutic platform is a suite of underpinning technologies including a Clostridia culture collection, a proprietary set of plasmid vectors, synthetic biology tools for advanced metabolic engineering, and an advanced in-vivo delivery mechanism using Clostridium.
Associated Fund UK Innovation & Science Seed Fund
Sector Medical / Biotechnology
CHAIN has been awarded £0.5M grant funding from Innovate UK, the UK’s Innovation agency,...read more
CHAIN Biotech has been awarded £0.5M grant funding from Innovate UK, the UK’s innovation...read more